Cited by 1,378Stress Responses and CortisolNeuropeptides and Animal PhysiologyNeuroendocrine regulation and behavior

The role of corticotropin-releasing factor in depression and anxiety disorders

Open access
Arborelius, L, Owens, MJ, Plotsky, PM, Nemeroff, CB·1999·Journal of Endocrinology

Abstract

Corticotropin-releasing factor (CRF), a 41 amino acid-containing peptide, appears to mediate not only the endocrine but also the autonomic and behavioral responses to stress. Stress, in particular early-life stress such as childhood abuse and neglect, has been associated with a higher prevalence rate of affective and anxiety disorders in adulthood. In the present review, we describe the evidence suggesting that CRF is hypersecreted from hypothalamic as well as from extrahypothalamic neurons in depression, resulting in hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and elevations of cerebrospinal fluid (CSF) concentrations of CRF. This increase in CRF neuronal activity is also believed to mediate certain of the behavioral symptoms of depression involving sleep and appetite disturbances, reduced libido, and psychomotor changes. The hyperactivity of CRF neuronal systems appears to be a state marker for depression because HPA axis hyperactivity normalizes following successful antidepressant treatment. Similar biochemical and behavioral findings have been observed in adult rats and monkeys that have been subjected to early-life stress. In contrast, clinical studies have not revealed any consistent changes in CSF CRF concentrations in patients with anxiety disorders; however, preclinical findings strongly implicate a role for CRF in the pathophysiology of certain anxiety disorders, probably through its effects on central noradrenergic systems. The findings reviewed here support the hypothesis that CRF receptor antagonists may represent a novel class of antidepressants and/or anxiolytics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1677/joe.0.1600001

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Alterations of the HPA axis is one of the most notable neurobiological findings in psychiatry.

    “Alterations of the hypothalamic–pituitary–adrenal (HPA) axis is one of the most notable neurobiological findings in psychiatry (1, 2).”

    From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [1]

    The Clinical findings in depression section describes HPA-axis hyperactivity in depressed patients as supported by a compelling number of studies, including repeatedly replicated cortisol findings. The Summary calls it well documented. Those passages support its importance in depression, but do not establish that HPA-axis alterations are among the most notable neurobiological findings across psychiatry. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • There is an excitatory reciprocal interaction between the HPA axis and the brainstem sympathetic locus coeruleus-norepinephrine system: CRH activates the LC, and NE activates hypothalamic CRH.

    “An important interplay is also the excitatory reciprocal interaction between the HPA axis and the brainstem sympathetic locus coeruleus (LC)-norepinephrine (NE) system: CRH activates the LC; in turn, NE, a known wake-promoting neurotransmitter, activates hypothalamic CRH [9, 10].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 14

  1. Amsterdam JD, Maislin G, Winokur A, Berwish N, Kling M & Gold P 1988 The oCRH test before and after clinical recovery from depression. Journal of Affective Disorders 14 213-222.
  2. Ba ´nki CM, Bissette G, Arato ´M, O'Connor L & Nemeroff CB 1987 Cerebrospinal fluid corticotropin-releasing factor-like immuno- reactivity in depression and schizophrenia. American Journal of Psychiatry 144 873-877.
  3. Ba ´nki CM, Karmacsi L, Bissette G & Nemeroff CB 1992a Cerebro- spinal fluid neuropeptides in mood disorders and dementia. Journal of Affective Disorders 25 39-46.
  4. Brown GW, Bifulco A & Harris TO 1987 Life events, vulnerability and onset of depression. British Journal of Psychiatry 150 30-42.
  5. Charney DS, Bremner JD & Redmond DE 1995 Noradrenergic neural substrates for anxiety and fear: clinical associations based on preclinical research. In Psychopharmacology: The Fourth Generation of Progress, pp 387-395. Eds FE Bloom & DJ Kupfer. New York: Raven Press.
  6. De Bellis MD, Gold PW, Geracioti TD, Listwak S & Kling MA 1993 Fluoxetine significantly reduces CSF CRH and AVP concentrations in patients with major depression. American Journal of Psychiatry 150 656-657.
  7. De Souza EB & Grigoriadis DE 1995 Corticotropin-releasing factor: physiology, pharmacology, and role in central neurvous system and immune disorders. In Psychopharmacology: The Fourth Generation of Progress, pp 505-517. Eds FE Bloom & DJ Kupfer. New York: Raven Press.
  8. Kalin NH 1990 Behavioral and endocrine studies of corticotropin- releasing hormone in primates. In Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide, pp 275-289. Eds EB De Souza & CB Nemeroff. Boca Raton, FL: CRC Press, Inc.
  9. Maes M & Meltzer HY 1995 The serotonin hypothesis of major depression. In Psychopharmacology: The Fourth Generation of Progress, pp 933-944. Eds FE Bloom & DJ Kupfer. New York: Raven Press.
  10. Plotsky P, Owens MJ & Nemeroff CB 1995a Neuropeptide alterations in affective disorders. In Psychopharmacology: The Fourth Generation of Progress, pp 971-981. Eds FE Bloom & DJ Kupfer. New York: Raven Press.
  11. Plotsky PM, Thrivikraman KV, Su Y, Caldji C, Sharma S & Meaney MJ 1998 The effects on neonatal rearing environment on CRF mRNA and CRF receptor levels in adult rat brain. Journal of Neuroscience. (In Press).
  12. Ed SC Risch. Washington DC: American Psychiatric Press.
  13. Van Bockstaele EJ, Colago EEO & Valentino RJ 1996 Corticotropin- releasing factor-containing axon terminals synapse onto catechol- amine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. Journal of Comparative Neurology 364 523-534.
  14. Weiss JM, Stout J, Aaron M, Owens MJ & Nemeroff CB 1994 Experimental studies of depression and anxiety: role of locus coeruleus and corticotropin-releasing factor. Brain Research Bulletin 35 561-572.

Cited by

Sorted by citations

Authors
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C.
Affiliations
Emory University (US)
Venue
Journal of Endocrinology
Published
1999-01-01
Volume
160
Issue
1
Pages
1-12
ISSN
  • 0022-0795 (ISSN-L)
  • 1479-6805
OpenAlex
W2143629083
Cited by
1,378
References
106
Citations by year
2026: 8 · 2025: 20 · 2024: 29 · 2023: 24 · 2022: 35 · 2021: 34 · 2020: 34 · 2019: 44 · 2018: 31 · 2017: 48 · 2016: 36 · 2015: 49 · 2014: 63 · 2013: 58 · 2012: 59
FWCI
4.58
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Swedish Institute
  • National Institutes of Health (DS-08705, MH-42088)
  • Medical Research Council
  • National Institute of Mental Health (R01MH042088, MH-50113, MH42088, R01MH050113)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
Keywords
corticotropin-releasing factor, depression, anxiety disorders, hypothalamic-pituitary-adrenal axis, early life stress, childhood abuse and neglect, CRF receptor antagonists, antidepressants, anxiolytics, noradrenergic system, psychomotor changes
MeSH terms
Adult, Animals, Anxiety Disorders, Child, Preschool, Corticotropin-Releasing Hormone, Depression, Disease Models, Animal, Humans, Hypothalamo-Hypophyseal System, Infant, Maternal Deprivation, Neurons, Pituitary-Adrenal System, Stress, Psychological, Receptors, Corticotropin-Releasing Hormone, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review